share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kewalramani Reshma

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kewalramani Reshma

福泰制药 | 4:持股变动声明-高管 Kewalramani Reshma
美股sec公告 ·  05/29 16:14
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals CEO & President, Kewalramani Reshma, completed a stock transaction on 05/24/2024 involving the sale of 1,565 shares of common stock at a price of $457.00 per share. The transaction resulted in a total market value of $715,205. Prior to this sale, Reshma exercised options to acquire the same number of shares at $187.53 per share. Following these transactions, Reshma's direct holdings in Vertex Pharmaceuticals amount to 121,374 shares. The sale took place under the transaction code 'S', indicating an open market or private sale, while the acquisition was coded 'M', signifying the exercise or conversion of derivative security.
Vertex Pharmaceuticals CEO & President, Kewalramani Reshma, completed a stock transaction on 05/24/2024 involving the sale of 1,565 shares of common stock at a price of $457.00 per share. The transaction resulted in a total market value of $715,205. Prior to this sale, Reshma exercised options to acquire the same number of shares at $187.53 per share. Following these transactions, Reshma's direct holdings in Vertex Pharmaceuticals amount to 121,374 shares. The sale took place under the transaction code 'S', indicating an open market or private sale, while the acquisition was coded 'M', signifying the exercise or conversion of derivative security.
Vertex Pharmaceuticals首席执行官兼总裁Kewalramani Reshma于2024年5月24日完成了一项股票交易,涉及以每股457.00美元的价格出售1,565股普通股。该交易的总市值为715,205美元。在此次出售之前,Reshma行使了期权,以每股187.53美元的价格收购了相同数量的股票。这些交易之后,瑞什玛在Vertex Pharmicals的直接持股量为121,374股。此次出售以交易代码 “S” 进行,表示公开市场或私下出售,而收购的代码为 “M”,表示行使或转换衍生证券。
Vertex Pharmaceuticals首席执行官兼总裁Kewalramani Reshma于2024年5月24日完成了一项股票交易,涉及以每股457.00美元的价格出售1,565股普通股。该交易的总市值为715,205美元。在此次出售之前,Reshma行使了期权,以每股187.53美元的价格收购了相同数量的股票。这些交易之后,瑞什玛在Vertex Pharmicals的直接持股量为121,374股。此次出售以交易代码 “S” 进行,表示公开市场或私下出售,而收购的代码为 “M”,表示行使或转换衍生证券。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息